Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC
Status:
Recruiting
Trial end date:
2024-01-25
Target enrollment:
Participant gender:
Summary
The efficacy of PD-1/PD-L1 combined with chemotherapy in the treatment of extensive
small-cell lung cancer is still unsatisfactory. PD-1/PD-L1 combined with chemotherapy and
anti-angiogenic drugs may achieve better efficacy.